Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer

PURPOSE: Neoadjuvant chemotherapy is the standard treatment for patients with locally advanced breast cancer and is increasingly considered for patients with operable disease. Recently, as many clinical trials have demonstrated favorable outcomes of anthracycline-taxane based regimen, this approach...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hong, Woo Sung, Jeon, Ja Young, Kang, Seok Yun, Jung, Yong Sik, Kim, Ji Young, Ahn, Mi Sun, Kang, Doo Kyoung, Kim, Tae Hee, Yim, Hyun Ee, An, Young-Sil, Park, Rae Woong, Kim, Ku Sang
Format: Artigo
Jezik:Inglês
Izdano: The Korean Surgical Society 2013
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699689/
https://ncbi.nlm.nih.gov/pubmed/23833754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/jkss.2013.85.1.7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items